Paragon Capital Management (Kansas)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-299,538
| Closed | -$9.95M | – | 59 |
|
|
2017
Q2 | $9.95M | Buy |
299,538
+65,696
| +28% | +$2.18M | 3.19% | 17 |
|
|
2017
Q1 | $7.5M | Buy |
233,842
+74,938
| +47% | +$2.4M | 2.35% | 21 |
|
|
2016
Q4 | $5.76M | Sell |
158,904
-21,197
| -12% | -$768K | 1.91% | 26 |
|
|
2016
Q3 | $8.29M | Buy |
180,101
+17,867
| +11% | +$822K | 2.8% | 20 |
|
|
2016
Q2 | $8.15M | Sell |
162,234
-200
| -0.1% | -$10K | 2.88% | 19 |
|
|
2016
Q1 | $8.69M | Buy |
162,434
+1,222
| +0.8% | +$65.4K | 3.39% | 16 |
|
|
2015
Q4 | $10.6M | Buy |
161,212
+10,453
| +7% | +$686K | 4.09% | 8 |
|
|
2015
Q3 | $8.51M | Sell |
150,759
-9,581
| -6% | -$541K | 3.31% | 17 |
|
|
2015
Q2 | $9.48M | Sell |
160,340
-5,683
| -3% | -$336K | 3.44% | 14 |
|
|
2015
Q1 | $10.3M | Buy |
166,023
+469
| +0.3% | +$29.2K | 3.86% | 8 |
|
|
2014
Q4 | $9.52M | Sell |
165,554
-2,260
| -1% | -$130K | 3.41% | 13 |
|
|
2014
Q3 | $9.02M | Sell |
167,814
-965
| -0.6% | -$51.9K | 3.46% | 12 |
|
|
2014
Q2 | $8.85M | Buy |
168,779
+18,650
| +12% | +$978K | 3.49% | 8 |
|
|
2014
Q1 | $7.93M | Sell |
150,129
-2,535
| -2% | -$134K | 3.4% | 11 |
|
|
2013
Q4 | $6.12M | Buy |
152,664
+5,368
| +4% | +$215K | 2.94% | 19 |
|
|
2013
Q3 | $5.56M | Buy |
147,296
+46,440
| +46% | +$1.75M | 2.85% | 22 |
|
|
2013
Q2 | $3.95K | Buy |
+100,856
| New | +$3.95K | 2.07% | 25 |
|